Amparo Solana-Bueno
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Amparo Solana-Bueno has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Antonio Albarracín-Marín-Blázquez
Coloproctology Unit, Department of Surgery, Reina Sofia University Hospital, 30003 Murcia, Spain
1 shared publication - Beatriz Martínez-Torres
Peritoneal Carcinomatosis Unit, Department of General and Digestive Surgery, Hospital Universitario de Fuenlabrada, 28942 Madrid, Spain
1 shared publication - Elena Ruiz-Úcar
Rey Juan Carlos University, Madrid, Spain
1 shared publication - Emilio Peña Ros
Servicio de Cirugía General y del Aparato Digestivo, Hospital General Universitario Reina Sofía, Murcia, España
1 shared publication - Jorge Alejandro Benavides-Buleje
Coloproctology Unit, Department of Surgery, Reina Sofia University Hospital, 30003 Murcia, Spain
1 shared publication - José Manuel Muñoz-Camarena
Coloproctology Unit, Department of Surgery, Reina Sofia University Hospital, 30003 Murcia, Spain
1 shared publication
Latest Publications
- Open Access
Postoperative Diet with an Oligomeric Hyperproteic Normocaloric Supplement versus a Supplement with Immunonutrients in Colorectal Cancer Surgery: Results of a Multicenter, Double-Blind, Randomized Clinical Trial
(1) Background: For normo-nourished colorectal cancer patients, the need for immunonutrients after elective surgery is not known. (2) Methods: Multicenter, randomized, double-blind, phase III clinical trial comparing the postoperative diet with 200 mL oligomeric hyperproteic normocaloric (OHN; experimental arm) supplement vs. 200 mL immunonutritional (IN) (active comparator) supplement twice a day for five days in 151 normo-nourished adult colorectal-resection patients following the multimodal rehabilitation ERAS protocol. The proportions of patients with complications (primary outcome) and those who were readmitted, hospitalized for p = 0.328). No significant differences were found for the rest of the variables. (4) Conclusions: IN supplement may not be necessary for the postoperative recovery of colorectal cancer patients under the ERAS regimen and with normal nutritional status at the time of surgery.
Open AccessPostoperative Diet with an Oligomeric Hyperproteic Normocaloric Supplement versus a Supplement with Immunonutrients in Colorectal Cancer Surgery: Results of a Multicenter, Double-Blind, Randomized Clinical Trial
(1) Background: For normo-nourished colorectal cancer patients, the need for immunonutrients after elective surgery is not known. (2) Methods: Multicenter, randomized, double-blind, phase III clinical trial comparing the postoperative diet with 200 mL oligomeric hyperproteic normocaloric (OHN; experimental arm) supplement vs. 200 mL immunonutritional (IN) (active comparator) supplement twice a day for five days in 151 normo-nourished adult colorectal-resection patients following the multimodal rehabilitation ERAS protocol. The proportions of patients with complications (primary outcome) and those who were readmitted, hospitalized for p = 0.328). No significant differences were found for the rest of the variables. (4) Conclusions: IN supplement may not be necessary for the postoperative recovery of colorectal cancer patients under the ERAS regimen and with normal nutritional status at the time of surgery.